News Results
There are 648,227 News Results
Sep 12, 2018
SILVER SPRING, Md., Sept. 12, 2018 /PRNewswire/ -- The U.S. Food and Drug Administration today announced a series of critical and historic enforcement actions related to the sale and marketing...
Sep 12, 2018
NASHVILLE, Tenn., Sept. 12, 2018 /PRNewswire/ -- Digital Book World (DBW) - the gathering of the wide world of publishing - announced the finalists in the 2018 Digital Book World...
Sep 13, 2018
NORTH CHICAGO, Ill., Sept. 13, 2018 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced new patient-reported outcomes data from three pivotal Phase 3 trials evaluating risankizumab,...
Sep 13, 2018
BOULDER, Colo., Sept. 13, 2018 /PRNewswire/ --
Sep 18, 2018
SAN DIEGO, Sept. 18, 2018 /PRNewswire/ -- Sempra Energy (NYSE: SRE) today announced that it has entered into a cooperation agreement with affiliates of Elliott Management Corporation (Elliott) and Bluescape...
Sep 18, 2018
Transaction broadens Cipher's Canadian portfolio providing entry into rapidly growing market
Sep 18, 2018
SILVER SPRING, Md., Sept. 18, 2018 /PRNewswire/ -- In recent days, I've warned about an epidemic of use of e-cigarettes among teens. We're in possession of data that shows a...
Sep 20, 2018
IRVINE, Calif., Sept. 20, 2018 /PRNewswire/ -- ATTOM Data Solutions , curator of the nation's premier property database, today released its 2018 U.S. Natural Hazard Housing Risk Index, which found...
Sep 20, 2018
BOULDER, Colo., Sept. 20, 2018 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) today announced that the European Commission (EC) has approved BRAFTOVI(®) in combination with MEKTOVI(®) for the treatment of...
Sep 21, 2018
TITUSVILLE, N.J., Sept. 21, 2018 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from a Phase 3 clinical study of the investigational product esketamine nasal...